Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 17.91% Profit Gain

August 08, 2023
On May 19, 2023, QuantWave, an automated forecasting platform, issued a price target forecast for ELI LILLY AND COMPANY stock, predicting a long position with a price of $436.12. This forecast proved to be accurate as on August 8, 2023, the stock reached the target price of $514.21, resulting in a profit of 17.91%.

The success of this forecast showcases the reliability and accuracy of QuantWave's analytical capabilities. Market analysis indicates that ELI LILLY AND COMPANY experienced positive momentum during the forecast period, potentially influenced by strong financial performance, favorable industry dynamics, and overall market trends.

Investors who utilized QuantWave's prediction for ELI LILLY AND COMPANY were able to capitalize on the significant profit opportunity presented by this successful forecast. This achievement highlights the potential for investors to make informed decisions and maximize returns using QuantWave's advanced forecasting algorithms.

QuantWave offers users access to predictions for a wide range of stocks, providing opportunities for profitable investments. For those interested in delving deeper into investment strategies, QuantSchool offers comprehensive educational resources on how to effectively utilize the QuantWave forecasting system to generate consistent income.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

NVDAFebruary 5, 2024QuantWave Achieves 39.77% Profit Target Forecast for NVIDIA CORPORATION  ~1 min.

QuantWave, the automated forecasting platform, successfully reached a price target forecast for the stock NVIDIA CORPORATION, yielding a profit of 39.77%....

WMTJune 4, 2024QuantWave Achieves 11.68% Profit Target Forecast for Walmart Inc. Stock  ~1 min.

QuantWave, the automated forecasting platform, successfully hit its price target forecast for Walmart Inc. stock on June 4, 2024....

AXPJanuary 15, 2025American Express Company Hits QuantWave's Price Target Forecast with 14.92% Profit  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted a long signal for American Express Company on October 22, with a price of $270.86....

NUEApril 4, 2025NUCOR CORPORATION Achieves Price Target Forecast with 14.51% Profit  ~1 min.

NUCOR CORPORATION has successfully reached the price target forecast set by QuantWave, resulting in a profit of 14.51%. The forecast signal was issued on January 7, 2025, with a price of 120.73 $....

HALJune 23, 2022QuantWave Achieves 17.91% Profit Target Forecast for Halliburton Company  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted a short direction for HALLIBURTON COMPANY's stock on May 20, 2022, when it was trading at 34.7 $. The forecasted target price of 28....